https://www.sm**h.com.au/business/companies/strict-advertising-rules-unveiled-for-covid-19-rapid-antigen-testing-products-20210823-p58l4t.html?utm_medium=Social&utm_source=Facebook#Echobox=1629718823
Atomo mentioned specifically:
"The renewed focus on rapid testing has boosted ASX-listed diagnostics businesses. Atomo Diagnostics, which has a rapid antigen test registered with the TGA, is up 17.5 per cent over the past month to 24c.Recently-listed Lumos Diagnostics is up 4.1 per cent."
Media Update, page-840
-
- There are more pages in this discussion • 1,006 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $3.016K | 150.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628443 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 291292 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |